Education and naloxone distribution to reduce opioid overdoses in African-American communities
Church-Tailored Opioid Overdose Education and Naloxone Distribution to Target Overdose and Stigma Among African-American Communities
This study is testing a program that helps African American communities learn about opioid overdoses and provides a life-saving medication called naloxone, all through local churches to make it easier for people to get the support they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10610386 on NIH RePORTER |
What this research studies
This research focuses on addressing the rising rates of opioid overdoses among African Americans by implementing a church-based education program. It aims to provide overdose education and distribute naloxone, a life-saving medication that can reverse opioid overdoses, within African-American communities. The program will tailor its approach to fit the cultural context of these communities, addressing stigma and enhancing understanding of substance use disorders. By leveraging the trusted environment of churches, the initiative seeks to increase awareness and access to overdose prevention resources.
Who could benefit from this research
Good fit: Ideal candidates for this research are African-American adults who are at risk of opioid overdose or are involved in substance use.
Not a fit: Patients who do not identify as African American or who are not at risk for opioid overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce opioid overdose deaths in African-American communities by increasing access to education and naloxone.
How similar studies have performed: Previous research has shown success with community-based overdose education and naloxone distribution programs, particularly in high-risk populations.
Where this research is happening
New York, United States
- New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC — New York, United States (Active)
Researchers
- Principal investigator: Jones, Jermaine D — New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC
- Study coordinator: Jones, Jermaine D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.